SKYE

Skye Bioscience, Inc. · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website -
Employees(FY) -
ISIN US83086J2006

Performance

-2.0%

1W

-5.77%

1M

+106.56%

3M

+750.69%

6M

+350.37%

YTD

+237.93%

1Y

Profile

-

Advanced Technical Analysis

Technical Analysis of SKYE 2024-05-10

Overview:

In the last 5 trading days, SKYE stock has shown a consistent downward trend in both price and volume. The moving averages (MA) have been declining, indicating a bearish trend. Momentum indicators like RSI and Stochastic Oscillator are also showing oversold conditions. Volatility has been increasing, as seen in the Bollinger Bands wide...

Recent News & Updates

2024-05-09 19:00
Skye Bioscience Highlights Novel Synthetic Cannabinoid-based Library Capable of Modulating the Endocannabinoid System to Treat Ocular Diseases at ARVO 2024 Annual Meeting(Globenewswire)
2024-05-06 23:59
Skye Bioscience Moves to Nasdaq, Hits Milestone in Clinical Program(Newsdirect)
2024-04-29 19:00
Skye Bioscience to Present Two Posters at Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting(Globenewswire)
2024-04-22 19:00
Skye Bioscience to Present at Upcoming Investment Conferences(Globenewswire)
2024-04-09 20:00
Skye Bioscience Uplists to The Nasdaq Global Market(Yahoo Finance)
2024-03-10 21:20
Skye Bioscience Announces $40 Million Private Placement Equity Financing(Yahoo Finance)
2024-03-03 18:00
Skye Bioscience Appoints Dr. Annalisa Jenkins to Board of Directors(Yahoo Finance)
2024-02-25 18:00
Skye Bioscience Completes Enrollment of Phase 2a Clinical Trial of SBI-100 Ophthalmic Emulsion in Glaucoma and Ocular Hypertension(Yahoo Finance)
2024-02-06 18:00
Skye Bioscience to Present at Oppenheimer Investor Conference(Yahoo Finance)
2024-01-28 19:00
Skye Bioscience Announces $50.25 Million Private Placement Equity Financing(Yahoo Finance)

Page 1 of 1

previousnext

Home

Market Lens

Ideas Explorer

History

Recent Activity